Evidence map›Paper›PMID 38217689›Full record

ArticleCerebellum (London, England)2024

Early-Life Social Determinants of SCA6 Age at Onset, Severity, and Progression.

Tiffany X Chen, Hannah L Casey, Chi-Ying R Lin, Theresa A Boyle, Jeremy D Schmahmann, Gilbert J L'Italien, Sheng-Han Kuo, Christopher M Gomez

Open access · hybridAbstract read
In one paragraph

Article in Cerebellum (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Tiffany X Chen *Department of Neurology, Columbia University Medical Center, New York, NY, USA.
Hannah L Casey *Department of Neurology, University of Chicago, Chicago, IL, USA.
Chi-Ying R LinDepartment of Neurology, Baylor College of Medicine, Houston, TX, USA.
Theresa A BoyleDepartment of Pathology and Cell Biology, University of South Florida, Tampa, FL, USA.
Jeremy D SchmahmannDepartment of Neurology, Massachusetts General Hospital, Ataxia Unit, Cognitive Behavioral Neurology Unit, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Harvard Medical School, Boston, MA, USA.
Gilbert J L'ItalienGlobal Health Outcomes and Epidemiology, Biohaven Pharmaceuticals, New Haven, CT, USA.
Sheng-Han KuoDepartment of Neurology, Columbia University Medical Center, New York, NY, USA. sk3295@columbia.edu.
Christopher M GomezDepartment of Neurology, University of Chicago, Chicago, IL, USA. cgomez@neurology.bsd.uchicago.edu.
University of Chicago · USBaylor College of Medicine · USBiohaven Pharmaceuticals (United States) · USColumbia University · USHarvard University · USJohns Hopkins University · USUniversity of South Florida · US

Funding

Targeting Cerebellar Endoplasmic Reticulum Calcium Handling in Essential TremorR01NS124854 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PHYLLIS L FAUST, Sheng-Han Kuo · 2022 to 2026
$2.9M
Targeting Cerebellar Excitatory Synapses for Tremor ProgressionR01NS118179 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KUO, SHENG-HAN · 2020 to 2024
$2.2M
Neurology Research Education and Mentorship ProgramUE5NS070697 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Jason Brant Carmel, Sheng-Han Kuo · 2024 to 2026
$475k
NINDS NIH HHS R01 NS118179NINDS NIH HHS R01 NS124854NINDS NIH HHS UE5 NS070697
6 · The paper itself

Abstract

SCA6 patients with the same size CAG repeat allele can vary significantly in age at onset (AAO) and clinical progression. The specific external factors affecting SCA6 have yet to be investigated. We assessed the effect of early life events on AAO, severity, and progression in SCA6 patients using a social determinant of health approach. We performed a survey of biological and social factors in SCA6 patients enrolled in the SCA6 Network at the University of Chicago. AAO of ataxia symptoms and patient-reported outcome measure (PROM) of ataxia were used as primary outcome measures. Least absolute shrinkage and selection operation (LASSO) regressions were used to identify which early life factors are predictive of SCA6 AAO, severity, and progression. Multiple linear regression models were then used to assess the degree to which these determinants influence SCA6 health outcomes. A total of 105 participants with genetically confirmed SCA6 completed the assessments. SCA6 participants with maternal difficulty during pregnancy, active participation in school sports, and/or longer CAG repeats were determined to have earlier AAO. We found a 13.44-year earlier AAO for those with maternal difficulty in pregnancy than those without (p = 0.008) and a 12.31-year earlier AAO for those active in school sports than those who were not (p < 0.001). Higher education attainment was associated with decreased SCA6 severity and slower progression. Early life biological and social factors can have a strong influence on the SCA6 disease course, indicating that non-genetic factors can contribute significantly to SCA6 health outcomes.

Indexed as

Age of OnsetDisease ProgressionSpinocerebellar AtaxiasAdultFemaleHumansMaleMiddle AgedSeverity of Illness IndexSocial Determinants of HealthYoung AdultAge of onsetCerebellar ataxiaCerebellumEpidemiologySpinocerebellar ataxia

Identifiers

PMID38217689
PMCPMC11269368
OpenAlexW4390840463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.